D-Glyceric acidemia

From WikiMD's Food, Medicine & Wellness Encyclopedia

D-Glyceric acidemia is a rare inherited metabolic disorder characterized by the body's inability to properly process the amino acid glycine. This condition is caused by a deficiency of the enzyme D-glycerate kinase, which is involved in the breakdown of glycine. The disorder can lead to a variety of symptoms, including developmental delay, seizures, and failure to thrive.

Symptoms[edit | edit source]

The symptoms of D-Glyceric acidemia can vary greatly from person to person. Some individuals may experience only mild symptoms, while others may have severe neurological complications. Common symptoms include:

Causes[edit | edit source]

D-Glyceric acidemia is caused by mutations in the GLYCTK gene, which provides instructions for making the enzyme D-glycerate kinase. This enzyme is involved in the breakdown of the amino acid glycine. When the enzyme is deficient, glycine and D-glyceric acid can build up in the body, leading to the symptoms of the disorder.

Diagnosis[edit | edit source]

The diagnosis of D-Glyceric acidemia is typically made through a combination of clinical examination, laboratory testing, and genetic testing. Laboratory tests may include blood and urine tests to check for elevated levels of glycine and D-glyceric acid. Genetic testing can confirm the diagnosis by identifying mutations in the GLYCTK gene.

Treatment[edit | edit source]

There is currently no cure for D-Glyceric acidemia, and treatment is focused on managing the symptoms of the disorder. This may include medications to control seizures, dietary modifications to limit the intake of glycine, and other supportive therapies.

See also[edit | edit source]

References[edit | edit source]


D-Glyceric acidemia Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD